Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia

Journal of Clinical Microbiology

Volumn 48, Issue 9, 2010, Pages 3258-3262

  Shorr, Andrew F ^a   Haque, Nadia ^b   Taneja, Charu ^c   Zervos, Marcus ^b   Lamerato, Lois ^b   Kothari, Smita ^d   Zilber, Sophia ^c   Donabedian, Susan ^b   Perri, Mary Beth ^b   Spalding, James ^d   Oster, Gerry ^c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c POLICY ANALYSIS INC PAI   (United States)

^d ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CONTROLLED STUDY; FEMALE; HEALTH CARE ASSOCIATED PNEUMONIA; HEALTH CARE COST; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITAL CHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NURSING HOME PATIENT; PATIENT CODING; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS INFECTION; FEES AND CHARGES; FEMALE; HEALTH EXPENDITURES; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, STAPHYLOCOCCAL; RETROSPECTIVE STUDIES; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; YOUNG ADULT;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 77956798549     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02529-09     Document Type: Article

References (19)

1. Benito, N., J. M. Miro, E. de Lazzari, C. H. Cabell, A. del Río, J. Altclas, P. Commerford, F. Delahaye, S. Dragulescu, H. Giamarellou, G. Habib, A. Kamarulzaman, A. S. Kumar, F. M. Nacinovich, F. Suter, C. Tribouilloy, K. Venugopal, A. Moreno, V. G. Fowler, Jr., et al. 2009. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann. Intern. Med. 150:586-594.
2. Haque, N., C. Taneja, G. Oster, A. Shorr, S. Zilber, C. Moore, J. Spalding, S. Kothari, and M. Zervos. 2008. Abstr. 48th Annu. Intersci. Conf. Antimi- crob. Agents Chemother. (ICAAC)-Infect. Dis. Soc. Am. (IDSA) 46th Annu. Meet., poster K-526.
3. Hidayat, L. K., D. I. Hsu, R. Quist, K. A. Shriner, and A. Wong-Beringer. 2006. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch. Intern. Med. 166:2138-2144.
4. Klevens, M. R., M. A. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, L. H. Harrison, R. Lynfield, G. Dumyati, J. M. Townes, A. S. Craig, E. R. Zell, G. E. Fosheim, L. K. McDougal, R. B. Carey, S. K. Fridkin, et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771. (Pubitemid 47598444)
5. Kollef, M. H., A. Shorr, Y. P. Tabak, V. Gupta, L. Z. Liu, and R. S. Johannes. 2005. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128: 3854-3862.
6. Labandeira-Rey, M., F. Couzon, S. Boisset, E. L. Brown, M. Bes, Y. Benito, E. M. Barbu, V. Vazquez, M. Höök, J. Etienne, F. Vandenesch, and M. G. Bowden. 2007. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315:1130-1133.
7. Lim, W. S., M. M. van der Eerden, R. Laing, W. G. Boersma, N. Karalus, G. I. Town, S. A. Lewis, and J. T. Macfarlane. 2003. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377-382.
8. Lina, G., Y. Piemont, F. Godail-Gamot, M. Bes, M. O. Peter, V. Gauduchon, F. Vandenesch, and J. Etienne. 1999. Involvement of Panton-Valentine leukocidin- producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:1128-1132.
9. Micek, S. T., K. E. Kollef, R. M. Reichley, N. Roubinian, and M. H. Kollef. 2007. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob. Agents Chemother. 51:3568-3573.
10. Murray, P. R., E. J. Baron, M. A. Pfaller, and R. H. Yolken (ed.). 2003. Manual of clinical microbiology, 8th ed. ASM Press, Washington, DC.
11. Practice Management Information Corp. 1997. International classification of diseases, 9th ed., clinical modification. Practice Management Information Corp., Los Angeles, CA.
12. Shindo, Y., S. Sato, E. Maruyama, T. Ohashi, M. Ogawa, N. Hashimoto, K. Imaizumi, T. Sato, and Y. Hasegawa. 2009. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 135:633-640.
13. Shorr, A., N. Haque, C. Taneja, C. Manerski, G. Oster, K. Reyes, and M. Zervos. 2008. Abstr. Am. Coll. Chest Phys., abstr. s15002.
14. Soriano, A., F. Marco, J. A. Martinez, E. Pisos, M. Almela, V. P. Dimova, D. Alamo, M. Ortega, J. Lopez, and J. Mensa. 2008. Influence of vancomycin minumum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46:193-200.
15. Stevens, D. L., Y. Ma, D. B. Salmi, E. McIndoo, R. J. Wallace, and A. E. Bryant. 2007. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 195:202-211.
16. Taneja, C., N. Haque, G. Oster, A. Shorr, S. Zilber, C. Moore, J. Spalding, S. Kothari, and M. Zervos. 2008. Abstr. 48th Annu. Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC)-Infect. Dis. Soc. Am. (IDSA) 46th Annu. Meet., poster K-4071.
17. Venditti, M., M. Falcone, S. Corrao, G. Licata, P. Serra, et al. 2009. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann. Intern. Med. 150:19-26.
18. Wikler, M. A., F. R. Cockerill, K. Bush, M. N. Dudley, G. M. Eliopoulos, D. J. Hardy, D. W. Hecht, J. F. Hindler, J. B. Patel, M. Powell, J. D. Turnidge, M. P. Weinstein, B. L. Zimmer, M. J. Ferraro, J. M. Swenson, et al. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard - 8th ed., vol. 29, no. 2. CLSI document M07-A8. CLSI, Wayne, PA.
19. Wootton, M., A. P. MacGowan, T. R. Walsh, and R. A. Howe. 2007. A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 45:329-332.